<?xml version="1.0" encoding="UTF-8"?>
<ref id="B18">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martin-Malo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Borchard</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Flühmann</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Mori</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Silverberg</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Jankowska</surname>
    <given-names>EA</given-names>
   </name>
  </person-group>. 
  <article-title>Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients</article-title>. 
  <source>ESC Heart Fail.</source> (
  <year>2019</year>) 
  <volume>6</volume>:
  <fpage>241</fpage>–
  <lpage>53</lpage>. 
  <pub-id pub-id-type="doi">10.1002/ehf2.12400</pub-id>
  <?supplied-pmid 30694615?>
  <pub-id pub-id-type="pmid">30694615</pub-id>
 </mixed-citation>
</ref>
